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Abstract: The aim of this study was to investigate the effect of altrenogest (ALT) treatment on follicular development and ovulation in
sows. Sows (parity 6–9; D0: weaning day) were assigned to four treatments as follows: control (no ALT treatment; n = 20), ALT-4–0
(ALT 20 mg/day, 5 days; D-4–D0; n = 20), ALT-4–2 (ALT 20 mg/day, 7 days; D-4–D2; n = 23), and 2ALT-4–2 (ALT 20 mg twice a day
[40 mg/day], 7 days; D-4–D2; n = 24). The sows in each group were further divided into three groups based on slaughter periods: day 1
(DF1) and day 4 (DF4) of the follicular phase, and after the initiation of estrus. The number of follicles was reduced on DF4 compared
to DF1 (P < 0.001). On DF1, follicular size (FS) of the control was larger than that of ALT-4–0, ALT-4–2, and 2ALT-4–2, but on DF4,
FS of ALT-4–2 and 2ALT-4–2 was larger than that of the control and ALT-4–0 (P < 0.001). The coefficient of variation of FS on DF4
was smaller in ALT-4–2 compared to the control and 2ALT-4–2 (P < 0.05). Ovulation rate was similar between groups (P ≥ 0.05). ALT
improved follicular growth and the homogeneity of FS without affecting ovulation.
Key words: Altrenogest, follicular development, ovulation, periweaning, sow

1. Introduction
In pigs, folliculogenesis determines embryogenesis by
influencing oocyte quality (1). Larger and more mature
follicles generated oocytes of better quality (2,3). In general,
selected large follicles at estrus are heterogeneous in size
(6.50–10.00 mm) (4), morphology, and hormonal status
(5), which reflects the further developmental potential of
embryos (1,6).
Altrenogest (ALT; a synthetic progestin) treatment
in sows during the weaning period improved follicular
development by increasing follicular size at the beginning of
the follicular phase and the preovulatory period. Moreover,
it improves reproductive performance, including a greater
ovulation rate (7), better estrus synchronization (8,9), and
a higher embryo survival rate (10).
Even though previous studies revealed improved
fertility of the sows that were treated with ALT was a

consequence of better follicular development, especially
increasing follicular size (11–13), the effect of ALT on the
homogeneity of preovulatory follicles was not mentioned.
Since follicular diversity is associated with the diversity
of embryonic development and survival during early
pregnancy (1,6), there is a need to investigate homogeneity
of preovulatory follicles for better fertility in sows.
Therefore, the objective of this study was to investigate
the effects of ALT treatment during the periweaning period
on the homogeneity of follicular development, ovulation
rate, and reproductive performance in sows.
2. Materials and methods
The study was conducted on a commercial sow breeding
farm housing 5000 sows and using an evaporative cooling
system during the rainy season (August to September
2013) in Chiang Mai, Thailand (18°47′25″N, 98°59′04″E).

* Part of this study was presented at the 23rd IPVS Congress, Cancun, Mexico, 8–11 June 2014.
** Correspondence: fvetacp@ku.ac.th
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2.1. Animals, diets, and housing
Animal manipulations were approved by the Animal Usage
and Ethics Committee of Kasetsart University (ACKU
03555). Eighty-seven lactating crossbred sows (Landrace
× Large White) that were expected to be replaced after
weaning during August 2013 because of old age were used
in this study. The parity, total born piglets or litter size
(LS), nursing piglets (NP), and piglets weaned per litter
(PWL) of sows were 7.55 ± 0.11, 16.41 ± 0.65, 11.87 ± 0.18,
and 11.82 ± 0.18, respectively. Moreover, the sows’ body
condition score (BCS) was assessed (14) at weaning to be
between 2.00 and 2.50 in range. The lactation length (LL)
of the sows in this study was 25.02 ± 0.21 days.
All sows were fed corn- and soybean-based diets during
gestation and lactation. Gestation diets were divided into
2 periods. The feeding level was controlled depending on
the sow’s BCS. During the 1st–11th weeks of gestation, the
diet contained 15.51% crude protein (CP), 3047.53 kcal/kg
metabolizable energy (ME), and 0.93% total lysine (Lys)
(BCS < 3.00: 2.80 kg/day, BCS = 3.00: 2.40 kg/day, BCS
> 3.00: 2.00 kg/day) and during the 12th–15th weeks of
gestation, the diet contained 16.41% CP, 3048.18 kcal/kg
ME, and 0.94% Lys (BCS ≥ 3.00: 2.80 kg/day, BCS < 3.00:
3.20 kg/day). During lactation, all sows were fed ad libitum
with the lactation diet. The lactation diet contained 18.08%
CP, 3314.47 kcal/kg ME, and 1.16% Lys. After weaning,
they were transferred from the lactation barn to the
gestation barn and they were kept in individual gestation
stalls. Prior to conception, they were fed ad libitum with
the lactation diet twice daily.
Minimum and maximum environmental temperatures
were recorded throughout the experiment. The average
temperature varied between a minimum of 24.40 ± 0.30
°C and a maximum of 26.60 ± 0.60 °C in the gestation
barn and a minimum of 23.20 ± 0.20 °C and a maximum
of 26.80 ± 0.50 °C in the lactation barn.
2.2. Altrenogest treatments
The sows were divided into four groups as follows: control,
ALT-4–0, ALT-4–2, and 2ALT-4–2. The sows in each group
were further divided into 3 slaughter periods for ovarian
structural examination: day 1 (DF1) and day 4 (DF4) of
the follicular phase, and after the initiation of estrus. Sows
were randomly distributed to treatment groups by parity.
The control group (n = 20) did not receive ALT (Altresyn®,
Ceva Animal Health). For the other groups, the sows were
fed a small amount of feed prior to receiving their large
meal to get ALT supplementation. ALT was supplemented
daily as a top dressing over a small portion of feed in
different doses and durations (ALT-4–0: 20 mg/day, for
5 days, D-4–D0, n = 20; ALT-4–2: 20 mg/day, for 7 days,
D-4–D2, n = 23; 2ALT-4–2: 20 mg twice a day [40 mg/
day]), for 7 days, D-4–D2, n = 24) (D0 = weaning day)
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(Table 1). ALT was given to the sows in the morning at
0600 hours, except for 2ALT-4–2, which received ALT
again at 1800 hours. The main four meals of the day were
at 0730, 1230, 1800, and 2000 hours in the lactation barn.
The main two meals of the day were at 0700–0730 and
1230–1330 in the gestation barn.
The sows that were slaughtered after estrus detection
were checked daily for estrus starting on day 1 after
treatment withdrawal (weaning or ALT) using fence-line
contact with a mature boar and carried out by trained farm
technicians. Estrus was indicated when the sows exhibited
a standing heat reflex during a back pressure test in the
presence of a boar between 0800–0900 and 1500–1600
hours. The sows were slaughtered 3.48 ± 0.29 days after the
initiation of estrus to assess the ovulation rate and ovarian
structures. The sows with a delayed return to estrus were
monitored for estrus daily until 14 days after treatment
withdrawal (weaning or ALT).
2.3. Follicular development
Ovaries were obtained from the slaughtered sows at the
specific periods described above and transported to the
laboratory in phosphate-buffered saline at 37 °C within
1.50 h (15). The ovaries were examined on the day of
slaughter and number of follicles (NF), follicular size in
diameter (FS), and ovarian structures (follicle - FL and
corpus luteum - CL) (16) were recorded for all animals.
The number of CLs revealed the ovulation rate.
Follicles larger than 1 mm were counted. The surface
follicular diameter was determined using a caliper. Besides
that, FS was categorized into 3 groups; small follicles
(<3.00 mm; S), medium follicles (3.00–6.90 mm; M), and
large follicles (≥7.00 mm; L). Follicles that were equal to
15.00 mm or larger were considered as large cystic follicles
(17,18). The sows that had large cystic follicles were not
included in this analysis.
2.4. Statistical analyses
Normality of variables was checked by using the Shapiro–
Wilk test. NF, mean FS, and coefficient of variation (CV)
of FS (the ratio of standard deviation of FS to mean of FS
expressed in percentage values) were analyzed by analysis
of covariance (ANCOVA) by using the GLM procedure
(SPSS 18, SPSS Inc., Chicago, IL, USA). Model 1 included
the effects of treatment, day of the follicular phase, and
the interaction between these two factors. In addition,
parity, BCS (19), LL (20), and NP (21) were considered
as cofactors in this model. When the treatment, day, or
interaction effect was significant, the Bonferroni method
was used for further multiple comparison tests and simple
effects analysis.
The number of CLs or ovulation rate was analyzed by
using ANCOVA that included terms for treatment, day of
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Table 1. Altrenogest (ALT) treatments in sows and slaughter periods.
Group1

Control

n

Day after weaning (D)
-4

-3

-2

-1

20

ALT-4–0

20

ALT-4–2

23

0

1

2

3

4

×

×

(n = 9)

(n = 5)

5

6

7

8

9

10

11

12

13

14

15

16

Heat detection (n = 6)

ALT

×

×

(n = 6)

(n = 7)

Heat detection (n = 7)

ALT

×

×

(n = 7)

(n = 8)

Heat detection (n = 8)

2ALT-4–2

24

2ALT

×

×

(n = 8)

(n = 8)

Heat detection (n = 8)
1
Group: Control = no ALT treatment; ALT-4–0 = ALT 20 mg/day, 5 days, D-4–D0; ALT-4–2 = ALT 20 mg/day, 7 days, D-4–D2; 2ALT-4–2 = ALT 20 mg twice a day (40 mg/
day), 7 days, D-4–D2).
ALT = Altrenogest treatment at 20 mg once a day.
2ALT = Altrenogest treatment at 20 mg twice a day (12-h interval).
D0 = Weaning day.
× = The sows in each group were slaughtered on day 1 (DF1) and day 4 (DF4) of the follicular phase and after the initiation of estrus. Day of follicular phase began 1 day after
weaning in the control group and 1 day after ALT withdrawal in the ALT-4–0, ALT-4–2, and 2ALT-4–2 groups. The numbers in parentheses represent the number of sows
slaughtered in the different periods.

Heat detection = The duration of estrus detection presented with gray color. The sows were slaughtered after the initiation of estrus.

the follicular phase, and the interaction between these two
factors (Model 2). Cofactors including parity, BCS, LL,
NP, NF, and days to slaughter (DTS) (the interval between
the initiation of estrus was detected and slaughtered day)
(4,22) were accounted for in Model 2. The Bonferroni
method was used for further multiple comparisons and
simple effects analysis when the treatment effect, day
effect, or interact effect was significant.
The treatment withdrawal (weaning or ALT) to estrus
interval comparison between the groups was analyzed by
ANCOVA using the GLM procedure (Model 3). Model
3 included the effects of treatment and cofactors such as
parity, BCS, LL, and NP. When the treatment effect was
significant, means of the four groups were further analyzed
by Bonferroni method.
Comparisons of the percentage of estrus expression
between the groups within 7 days and 14 days after
treatment (weaning or ALT) withdrawal were evaluated
by using the Fisher–Freeman–Halton exact test (23) and
Bonferroni corrected pairwise technique (24).
The significance level was considered as P < 0.05. The
data in the text and tables are presented as mean ± SEM.

3. Results
A sow in the control group, two sows in ALT-4–0, and one
sow in ALT-4–2 had large cystic follicles. Therefore, they
were excluded from this study.
The cofactors including parity, BCS, LL, NP, and DTS
were not significantly different between groups (Table 2).
3.1. Number of follicles (NF), follicular size (FS), and
variation of follicular size
NF and FS changed throughout the process of follicular
development. The reduction of NF was noticeable on
DF4 when compared to DF1 (P < 0.001) after treatment
withdrawal, although there were no differences between
groups (P ≥ 0.05) (Table 3). While FS was affected by the
interaction between groups and days of the follicular phase
(P < 0.001) (Table 3), FS was larger on DF4 compared to
DF1 (P < 0.05). On DF1, FS was larger (P < 0.05) in the
control group compared to the ALT-4–0, ALT-4–2, and
2ALT-4–2 groups. On DF4, FS in the ALT-4–2 and 2ALT4–2 groups was larger (P < 0.05) than in the control and
ALT-4–0 groups, and the ALT-4–2 group had the greatest
FS (Table 3).
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Table 2. Comparisons of covariates between groups.
Covariate

Parity

Body condition scores (BCS)

Lactation length (LL)

Nursing piglets (NP)

Days to slaughter (DTS)

Group1

n

Mean ± SEM

Control

22

7.64 ± 0.15

ALT-4–0

19

7.26 ± 0.15

ALT-4–2

23

7.61 ± 0.17

2ALT-4–2

24

7.92 ± 0.16

Control

22

2.52 ± 0.06

ALT-4–0

19

2.68 ± 0.07

ALT-4–2

23

2.57 ± 0.08

2ALT-4–2

24

2.42 ± 0.07

Control

22

24.73 ± 0.16

ALT-4–0

18

24.56 ± 0.42

ALT-4–2

23

25.04 ± 0.35

2ALT-4–2

24

25.50 ± 0.12

Control

21

11.38 ± 0.27

ALT-4–0

19

11.47 ± 0.38

ALT-4–2

23

11.91 ± 0.31

2ALT-4–2

24

11.63 ± 0.38

Control

6

3.50 ± 0.22

ALT-4–0

7

3.14 ± 0.14

ALT-4–2

8

3.00 ± 0.27

2ALT-4–2

8

4.88 ± 0.90

Significance

NS

NS

NS

NS

NS

Group: Control = no ALT treatment; ALT-4–0 = ALT 20 mg/day, 5 days, D-4–D0; ALT-4–2 = ALT 20 mg/
day, 7 days, D-4–D2; 2ALT-4–2 = ALT 20 mg twice a day (40 mg/day), 7 days, D-4–D2).
NS = Not significant (P ≥ 0.05).

1

Table 3. Number of follicles (NF), follicular size (FS), and coefficient of variation of follicular size (CV) among groups and between days
within group (mean ± SEM).
Group1
Variables

Day

2

Cofactors

Control

ALT-4–0

ALT-4–2

2ALT-4–2

n

Mean ± SEM

n

Mean ± SEM

n

Mean ± SEM

n

Mean ± SEM

Number of follicles

DF1

8

85.25 ± 7.19 x

6

98.17 ± 6.90 x

7

86.29 ± 8.3 x

8

85.00 ± 7.13 x

(NF)

DF4

5

60.80 ± 5.03 y

6

80.50 ± 13.83 y

7

45.00 ± 8.50 y

8

59.50 ± 5.19 y

Follicular size

DF1

8

3.86 ± 0.07 ax

6

3.39 ± 0.05 bx

7

3.41 ± 0.08 bx

8

3.10 ± 0.06 cx

(FS, mm)

DF4

5

4.61 ± 0.13

6

4.30 ± 0.08

7

6.30 ± 0.14

8

5.20 ± 0.11 cy

DF1

8

39.74 ± 4.10

6

36.91 ± 2.45

7

45.01 ± 4.39 x

8

43.07 ± 3.79

DF4

5

42.01 ± 5.24 a

6

39.97 ± 3.34 ab

7

24.81 ± 3.96 by

8

40.55 ± 5.27 a

DF1

8

15.15 ± 10.00 abx

6

0.55 ± 0.25 ax

7

17.79 ± 13.83 bx

8

1.43 ± 0.74 abx

DF4

5

28.18 ± 11.27 aby

6

16.63 ± 5.54 ay

7

66.85 ± 12.75 by

8

37.54 ± 9.48 aby

DF1

8

56.55 ± 6.82 ab

6

74.52 ± 2.91 a

7

49.22 ± 8.35 b

8

56.27 ± 8.02 ab

DF4

5

53.83 ± 9.01

6

66.64 ± 6.13

a

7

26.74 ± 9.72

b

8

46.96 ± 8.09 ab

DF1

8

28.30 ± 5.36 x

6

24.93 ± 2.93 x

7

32.99 ± 6.18 x

8

42.30 ± 8.11 x

DF4

5

17.99 ± 7.98 y

6

16.72 ± 3.85 y

7

6.41 ± 3.23 y

8

15.51 ± 5.64 y

CV (%)

L follicles (%)

M follicles (%)

S follicles (%)

ay

ab

ay

by

Significance

Parity

BCS

LL

NP

Group

Day

Group
× day

NS

NS

NS

NS

NS

***

NS

NS

*

***

NS

***

***

***

NS

NS

*

NS

NS

**

**

NS

NS

NS

NS

*

***

NS

NS

NS

NS

NS

**

NS

NS

NS

NS

NS

NS

NS

***

NS

Group: Control = no ALT treatment; ALT-4–0 = ALT 20 mg/day, 5 days, D-4–D0; ALT-4–2 = ALT 20 mg/day, 7 days, D-4–D2; 2ALT-4–2 = ALT 20 mg twice a day (40 mg/day), 7 days, D-4–D2).
a, b, c
Day: DF1 = day 1 of the follicular phase, DF4 = day 4 of the follicular phase.
Values differed significantly among groups (P < 0.05).
x, y
Cofactors: BCS = body condition score; LL = lactation length; NP = number of nursing piglets.
Values differed significantly between days within group (P < 0.05).
L follicles (≥7.0 mm), M follicles (3.0–6.9 mm), and S follicles (< 3.0 mm).
NS = Not significant (P ≥ 0.05), * = P < 0.05, ** = P < 0.01, *** = P < 0.001.
1

2
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The variation of follicular size (CV) was influenced
by interaction between groups and days (P < 0.01). It was
similar among groups on DF1. However, on DF4, the ALT4–2 group had less variation (P < 0.05) than the control
and 2ALT-4–2 groups. Moreover, in comparison between
DF1 and DF4 within the same group, the variation of FS
did not change, except for the ALT-4–2 group, which had
reduced CV (P < 0.05) when compared to DF1 (Table 3).
3.2. The percentage of follicles classified by size
The percentage of L follicles increased from DF1 to DF4
in all groups but varied between groups. The ALT-4–2
group had a higher percentage of L follicles but it was
not significantly different from the control and 2ALT-4–
2 groups. However, it was higher (P < 0.05) than that of
ALT-4–0 group.
There was no effect of days on treatment, but an effect
of groups was detected on the difference in the percentage
of M follicles. The lowest percentage of M follicles was
noticeable in the ALT-4–2 group, but it did not differ from
the control and 2ALT-4–2. The ALT-4–0 group had the
highest percentage of M follicles.
The percentage of S follicles on DF4 was lower when
compared to DF1. However, it did not vary among groups
(Table 3).
3.3. Ovulation rate
After estrus expression, the numbers of CLs, which
indicated the ovulation rate, were similar among the four
groups (Table 4).
3.4. Treatment withdrawal (weaning or ALT) to estrus
interval (TWEI) and percentage of estrus within 7 days
and 14 days following treatment (weaning or ALT)
withdrawal
ALT treatment affected TWEI (P < 0.001). ALT treatment
twice a day (2ALT-4–2) extended TWEI, which was longer
(P < 0.05) than that of the control, ALT-4–0, and ALT-4–2.

Moreover, ALT treatment for 7 days postponed TWEI of
the sows in ALT-4–2 when compared to the control. TWEI
was not different between the control and ALT-4–0 (Table
5).
ALT treatment twice a day (2ALT-4–2) decreased (P <
0.05) the percentage of estrus within 7 days after treatment
(ALT) withdrawal when compared to the control and ALT4–0, but it was similar to ALT-4–2. However, all sows were
detected to be in estrus by 14 days following treatment
withdrawal (Table 6).
4. Discussion
The greater advance of follicular growth decreased NF on
DF4 when compared to DF1. The reason for this could
be the atresia of follicles during development. During
follicular development, FSH is responsible for the growth
of small and medium follicles on the ovary surface
(recruitment) (25). After that, LH will promote further
growth of these follicles to preovulatory size (selection)
(25). In the current study, some of the developing follicles
were in atresia, probably due to the changes of hormonal
status and the level of LH receptors (26). Atresia of follicles
occurs in both the recruitment and selection processes
(26). After ALT treatment, the growing of medium-sized
follicles may generate inhibin dimers, which are specific
for FSH inhibition (26). Furthermore, when these follicles
develop to larger than 6 mm, they contribute to a higher
level of peripheral 17β-estradiol, which has a negative
effect on the hypothalamus; this subsequently reduces the
concentrations of GnRH, LH, and FSH (26). Therefore,
some of the small and medium follicles that need FSH for
growth and have insufficient LH receptors will be in atresia
(27).
ALT treatment could delay follicular growth. The
suppressive effect on follicular growth depended on the
dose and duration of ALT treatment. Besides that, during

Table 4. Comparisons of ovulation rate (based on the number of CLs) after estrus expression between groups (mean ± SEM).
Group1

n

Ovulation rate

Control

6

23.17 ± 2.17

ALT-4–0

6

27.67 ± 2.97

ALT-4–2

8

30.25 ± 1.66

2ALT-4–2

8

26.38 ± 4.62

Cofactors
Parity

BCS

DTS

LL

NP

NF

NS

NS

NS

NS

NS

NS

Significance

NS

Group: Control = no ALT treatment; ALT-4–0 = ALT 20 mg/day, 5 days, D-4–D0; ALT-4–2 = ALT 20 mg/day, 7 days, D-4–D2; 2ALT4–2 = ALT 20 mg twice a day (40 mg/day), 7 days, D-4–D2).
Cofactors: BCS = body condition score; DTS = days to slaughter; LL = lactation length; NP = number of nursing piglets; NF = number
of follicles.
NS = not significant (P ≥ 0.05).
1
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Table 5. The difference of treatment withdrawal (weaning or ALT) to estrus interval (TWEI) among groups (mean ± SEM).
Group1

n

TWEI (days)

Control

6

5.00 ± 0.00 a

ALT-4–0

6

6.00 ± 0.00 ab

ALT-4–2

8

7.25 ± 0.25 b

2ALT-4–2

8

8.88 ± 0.52 c

Cofactors
Parity

BCS

LL

NP

NS

NS

NS

NS

Significance

***

Group: Control = no ALT treatment; ALT-4–0 = ALT 20 mg/day, 5 days, D-4–D0; ALT-4–2 = ALT 20 mg/day, 7 days, D-4–D2; 2ALT4–2 = ALT 20 mg twice a day (40 mg/day), 7 days, D-4–D2).
Cofactors: BCS = body condition score; LL = lactation length; NP = number of nursing piglets.
a, b, c
Values differed significantly among groups (P < 0.05).
NS = Not significant (P ≥ 0.05), *** = P < 0.001.

1

Table 6. The percentage of estrus (%) within 7 days and 14 days after treatment withdrawal (weaning or ALT).
Group1
Day2

Control

ALT-4–0

n

%

7

6/6

100.00

14

6/6

100.00

a

ALT-4–2

n

%

7/7

100.00

7/7

100.00

a

Significance

2ALT-4–2

n

%

5/8

62.50

8/8

100.00

ab

n

%

1/8

12.50 b

***

8/8

100.00

NS

Group: Control = no ALT treatment; ALT-4–0 = ALT 20 mg/day, 5 days, D-4–D0; ALT-4–2 = ALT 20 mg/day, 7 days, D-4–D2; 2ALT4–2 = ALT 20 mg twice a day (40 mg/day), 7 days, D-4–D2).
2
Day: days after treatment (weaning or ALT) withdrawal.
a, b
Values differed significantly among groups (P < 0.05).
NS = Not significant (P ≥ 0.05), *** = P < 0.001.
1

ALT treatment until after weaning, it may prevent ovulation.
Therefore, an accumulation of large-sized follicles without
ovulation led to a larger FS of follicles on DF4 in ALT-4–2
and 2ALT-4–2 when compared to the control and ALT-4–
0 groups. Further evidence was the increasing percentage
of large follicles on DF4 in both groups. The slow growth
of follicles in this study agreed with a previous report that,
during ALT treatment, the suppressive effect of ALT on
LH pulse sustained the follicular development of larger
follicles up to a size of approximately 5 mm but did not
promote final development to preovulatory size (28).
However, a different aspect was found, which was that
ALT treatment at 20 mg/day for 7 days did not obstruct
follicular development to a large size completely, so large
follicles on DF1 in ALT-4–2 were present. Administration
of ALT at 20 mg/day allowed further growth of follicles
because the period of 12 h after ALT treatment had more
variability of LH pulse and concentration that could permit
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follicular development (28). Meanwhile, ALT treatment
at 40 mg/day (20 mg twice a day, 12-h interval; 2ALT4–2) could inhibit or delay follicular growth completely.
Thus, the average FS of ALT-4–2 was larger than that of
the 2ALT-4–2 group on DF4. Moreover, the duration of
the ALT treatment influenced FS; a short duration of ALT
treatment (5 days, ALT-4–0) allowed less time for follicular
growth than the long duration (ALT-4–2 and 2ALT-4–2
groups). In addition, several previous studies mentioned
that ALT treatment produced larger FS at the beginning
of the follicular phase than in the control (11,12). The
period of ALT treatment may be involved in this disparity.
The shorter period of ALT treatment during lactation and
the longer period of ALT treatment after weaning in the
previous studies, such as D-1–D7, D-1–D14 (11) and D-1–
D6, D-3–D6 (12), allowed a longer period for follicular
growth without the suppressive effect from suckling,
which inhibited the GnRH pulse generator; subsequently,
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LH concentration and LH pulsatility was decreased (29).
It was demonstrated in this study that the period of ALT
treatment was very important for FS at the beginning of
the follicular phase.
Heterogeneity of FS is always present in both gilts
and sows (30). The follicular diameter of the ovulatory
population varies in size by at least 2–3 mm (31).
However, inhibiting ovulation during ALT treatment (32)
improved the homogeneity of follicles (CV) of the ALT4–2 group compared to the control group. Increasing
FS without ovulation could generate a pool of similarly
sized preovulatory follicles by promoting the later smaller
follicles to grow to the same size as the former larger
size follicles. Nevertheless, the dose and duration of ALT
treatment specified the CV of FS by determining the
growing rate of smaller follicles to larger size follicles. The
greater intensity of ALT suppression of the 2ALT-4–2 group
delayed follicular growth to reach larger size more so than
in ALT-4–2; therefore, the CV of the 2ALT-4–2 group was
higher than that of the ALT-4–2 group. A short duration
of ALT treatment (ALT-4–0) did not provide enough time
for small follicles to develop to large follicles, so the CV
of the ALT-4–0 group did not reduce between DF1 and
DF4. Similarly, in the control sows, the heterogeneity of
developing follicles still remained and it was unchanged
between DF1 and DF4. Therefore, the proper dose and
duration of ALT treatment (ALT-4–2) could generate
more homogeneous follicles before ovulation.
ALT treatment did not affect ovulation rate after
withdrawal. The ovulation rate of the sows after showing
estrous signs was not different among groups. This result
confirmed a previous study finding that ALT treatment
once a day (15–20 mg/day) did not affect ovulation rate
when the lactating period was in the range of 18–24 days
(11). In the present study, the lactating period varied
between 24.73 and 25.50 days. In contrast to early weaned
sows (lactating period equal to 12 days), ALT treatment
(20 mg/day) after weaning from D13 to D24 could improve
the ovulation rate (7).

The dose and duration of ALT treatment affected
TWEI and the percentage of estrus expression. Higher
dosages and longer periods of ALT treatment resulted in
longer TWEI and lower percentage of estrus within 7 days
after treatment withdrawal. This effect might possibly be
related to LH secretion. ALT treatment decreased GnRH
release and reduced LH and FSH secretion (33), and it
postponed weaning to estrus in sows (9). Likewise, ALT,
which is a synthetic progesterone, might compromise
the frequency of LH pulses, similar to the effect of a
negative energy balance that prolonged the weaning to
estrus interval (34,35). High levels of progesterone (or
ALT) possibly inhibited the signal for the initiation of
follicular recruitment (25). For these reasons, TWEI was
lengthened in ALT-treated sows when compared to the
control sows. This result was similar to a previous report
that ALT treatment for 7 days (D-2–D5) postponed estrus
expression to 7.40 ± 0.10 days after withdrawal (10).
However, the suppressive effect of ALT on LH pulse was
reversible because all ALT-treated sows could express
estrous signs within 14 days after withdrawal.
In conclusion, a proper dose and duration of ALT
treatment (20 mg/day for 7 days; ALT-4–2) could improve
FS and decrease the CV of FS without a negative effect on
ovulation rate after withdrawal. ALT-4–2 supplementation
during the periweaning period in sows might increase sow
reproductive performance by improving follicular growth
and homogeneity.
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